Publications
31
Citations
539
Est. group size
~6
Recurring co-author estimate
Active years
14
Publishing since 2013
Typically publishes in teams of ~6 · 33% small-team papers (≤3 authors) · across 6 venues
- Beyond Fibrinolysis: Urokinase Plasminogen Activator as an Early Regulator of Obesity
Arteriosclerosis Thrombosis and Vascular Biology · 2026
- Synergistic effects of the Aβ/fibrinogen complex on synaptotoxicity, neuroinflammation, and blood–brain barrier damage in Alzheimer's disease models
Alzheimer s & Dementia · 2025
- Lecanemab blocks the effects of the Aβ/fibrinogen complex on blood clots and synapse toxicity in organotypic culture
Proceedings of the National Academy of Sciences · 2024
- Lecanemab Blocks the Effects of the Aβ/Fibrinogen Complex on Blood Clots and Synapse Toxicity in Organotypic Culture
bioRxiv (Cold Spring Harbor Laboratory) · 2024
- Vascular Dysfunction in Alzheimer’s Disease: Alterations in the Plasma Contact and Fibrinolytic Systems
International Journal of Molecular Sciences · 2023
- Corrigendum to “Tibolone protects T98G cells from glucose deprivation” [J. Steroid Biochem. Mol. Biol. 144 (2014) 294–303]
The Journal of Steroid Biochemistry and Molecular Biology · 2023
- bioRxiv (Cold Spring Harbor Laboratory)×3
- Journal of Neuroinflammation×2
- Translational Stroke Research×1
- Journal of Biological Chemistry×1
- Blood×1
- Susantha K. Ganegamage
Medicine · Purdue University West Lafayette
- Aditi Verma
Medicine · University of Michigan
- Jennifer C. Lee
Medicine · Indiana University
- Kris Mann
Medicine · University of Michigan
- Jason R. Cannon
Medicine · Purdue University West Lafayette
This profile was generated automatically from public scholarly data (OpenAlex). Group size and activity levels are estimates derived from co-authorship patterns.
Last updated Jul 25, 2026.
Claim or correct this profile